Literature DB >> 8755934

Segregation analysis indicates a major gene in the control of interleukine-5 production in humans infected with Schistosoma mansoni.

V Rodrigues1, L Abel, K Piper, A J Dessein.   

Abstract

The interleukine-5 (IL-5) is a hormone of the immune system that is the main regulator of eosinopoiesis, eosinophil maturation and activation, and immunoglobulin A production. Thus, IL-5 contributes in several ways to human immune defenses against various pathogens, including helminths and infectious agents of the digestive and respiratory tracts. On the other hand, the increase in eosinophil number and the activation of these cells, which both have been related to elevated IL-5 production, are the cause of severe pathological disorders, as in asthma or hypereosinophilic syndromes. Although the immunological pathways leading to IL-5 synthesis have been identified, the reasons for the large variability observed in IL-5 production among subjects exposed to comparable antigenic stimulation are unknown. To investigate the role of genetic factors in this variability, we conducted a segregation analysis in a Brazilian population infected by the helminth parasite Schistosoma mansoni. The analysis was performed on IL-5 levels produced by blood mononuclear cells of these subjects after in vitro restimulation with either parasite extracts (IL-5/schistosomula sonicates [SS] phenotype) or a T-lymphocyte mitogen (IL-5/phytohemagglutin [PHA]). The results provide clear evidence for the segregation of a codominant major gene controlling IL-5/SS and IL-5/PHA production and accounting for 70% and 73% of the phenotypic variance, respectively; the frequency of the allele predisposing to low IL-5 production was approximately .22 for both phenotypes. No significant relationship was found between these genes and the gene controlling infection intensities by S. mansoni detected in a previous study. Linkage studies are ongoing to locate those genes that would help to characterize the genetic factors involved in pathological conditions such as severe helminth infections and allergic diseases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755934      PMCID: PMC1914735     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  53 in total

1.  Equivalence of the mixed and regressive models for genetic analysis. I. Continuous traits.

Authors:  F M Demenais; G E Bonney
Journal:  Genet Epidemiol       Date:  1989       Impact factor: 2.135

Review 2.  Molecular mechanisms of immunoglobulin A defense.

Authors:  N K Childers; M G Bruce; J R McGhee
Journal:  Annu Rev Microbiol       Date:  1989       Impact factor: 15.500

3.  Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice.

Authors:  R L Coffman; B W Seymour; S Hudak; J Jackson; D Rennick
Journal:  Science       Date:  1989-07-21       Impact factor: 47.728

4.  Combined linkage and segregation analysis using regressive models.

Authors:  G E Bonney; G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1988-07       Impact factor: 11.025

5.  Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5.

Authors:  B H van Leeuwen; M E Martinson; G C Webb; I G Young
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

6.  Human eosinophil hematopoiesis studied in vitro by means of murine eosinophil differentiation factor (IL5): production of functionally active eosinophils from normal human bone marrow.

Authors:  E J Clutterbuck; C J Sanderson
Journal:  Blood       Date:  1988-03       Impact factor: 22.113

7.  Recombinant human interleukin 5 is a selective eosinophil chemoattractant.

Authors:  J M Wang; A Rambaldi; A Biondi; Z G Chen; C J Sanderson; A Mantovani
Journal:  Eur J Immunol       Date:  1989-04       Impact factor: 5.532

8.  Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production.

Authors:  E Sonoda; R Matsumoto; Y Hitoshi; T Ishii; M Sugimoto; S Araki; A Tominaga; N Yamaguchi; K Takatsu
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

9.  Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors.

Authors:  Y Yamaguchi; T Suda; J Suda; M Eguchi; Y Miura; N Harada; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

10.  Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.

Authors:  Y Yamaguchi; Y Hayashi; Y Sugama; Y Miura; T Kasahara; S Kitamura; M Torisu; S Mita; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  6 in total

1.  Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens.

Authors:  A Jepson; W Banya; F Sisay-Joof; M Hassan-King; C Nunes; S Bennett; H Whittle
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  Fc epsilon R1-beta polymorphism and total serum IgE levels in endemically parasitized Australian aborigines.

Authors:  L J Palmer; P D Paré; J A Faux; M F Moffatt; S E Daniels; P N LeSouëf; P R Bremner; E Mockford; M Gracey; R Spargo; A W Musk; W O Cookson
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

3.  Dysregulation of interleukin 5 expression in familial eosinophilia.

Authors:  S Prakash Babu; Y-Y K Chen; S Bonne-Annee; J Yang; I Maric; T G Myers; T B Nutman; A D Klion
Journal:  Allergy       Date:  2017-04-18       Impact factor: 13.146

Review 4.  Genetic epidemiology of infectious diseases in humans: design of population-based studies.

Authors:  L Abel; A J Dessein
Journal:  Emerg Infect Dis       Date:  1998 Oct-Dec       Impact factor: 6.883

Review 5.  Th1/Th2 balance in infection.

Authors:  C Infante-Duarte; T Kamradt
Journal:  Springer Semin Immunopathol       Date:  1999

Review 6.  Immunology of human schistosomiasis.

Authors:  D G Colley; W E Secor
Journal:  Parasite Immunol       Date:  2014-08       Impact factor: 2.280

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.